--- title: "12:49 ET\n \n \n Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights" type: "News" locale: "en" url: "https://longbridge.com/en/news/271968530.md" description: "Halper Sadeh LLC is investigating TreeHouse Foods, Amicus Therapeutics, and REV Group for potential violations of federal securities laws related to their sales. Shareholders are encouraged to contact the firm to discuss their rights and options, as there may be limited time to enforce them. The firm may seek increased consideration or additional disclosures on behalf of shareholders, working on a contingent fee basis. Interested parties can reach out to Halper Sadeh LLC for free consultations regarding their legal rights." datetime: "2026-01-08T17:50:26.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/271968530.md) - [en](https://longbridge.com/en/news/271968530.md) - [zh-HK](https://longbridge.com/zh-HK/news/271968530.md) generator: "portal-rs" --- # 12:49 ET Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights ***Shareholders should contact the firm as there may be limited time to enforce your rights.*** , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: **TreeHouse Foods, Inc. (NYSE: THS)'s** sale to Industrial F&B Investments III Inc. for $22.50 in cash per share plus a contingent value right. **If you are a TreeHouse shareholder,** **click here to learn more about your rights and options****.** **Amicus Therapeutics, Inc. (NASDAQ: FOLD)'s** sale to BioMarin Pharmaceutical Inc. for $14.50 per share. **If you are an Amicus shareholder, click here to learn more about your legal rights and options**. **REV Group, Inc. (NYSE: REVG)'s** sale to Terex Corporation for 0.9809 of a share of the combined company and $8.71 in cash for each REV Group share. **If you are a REV Group shareholder, click here to learn more about your legal rights and options**. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. **We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.** Shareholders are encouraged to contact the firm **free of charge** to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email \[email protected\] or \[email protected\]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 \[email protected\] \[email protected\] https://www.halpersadeh.com SOURCE Halper Sadeh LLP ### Related Stocks - [FOLD.US](https://longbridge.com/en/quote/FOLD.US.md) - [THS.US](https://longbridge.com/en/quote/THS.US.md) - [REVG.US](https://longbridge.com/en/quote/REVG.US.md) ## Related News & Research - [BioMarin Targets Faster Deleveraging as Amicus Deal Expands Rare-Disease Growth](https://longbridge.com/en/news/295676988.md) - [Terex Completes REV Group Acquisition, Enhancing Vehicle Portfolio](https://longbridge.com/en/news/294545736.md) - [Amicus Therapeutics Repays and Terminates 2023 Blackstone Credit Agreement Following Merger](https://longbridge.com/en/news/284245917.md) - [Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week High - Time to Buy?](https://longbridge.com/en/news/279443033.md) - [E-ONE, a Leader in Firefighting Equipment Manufacturing, Expands Production Capacity | TEX Stock News](https://longbridge.com/en/news/279459311.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**